PRO1184 for Advanced Solid Tumors
Conditions: Ovarian Cancer; Primary Peritoneal Carcinoma; Fallopian Tube Cancer; Endometrial Cancer; Non-small Cell Lung Cancer; Mesothelioma; Triple Negative Breast Cancer; HER2-negative Breast Cancer; Hormone Receptor-positive Breast Cancer Intervention: Drug: PRO1184 Sponsor: ProfoundBio US Co. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2022 Category: Research Source Type: clinical trials